NanoViricides Inc. (NNVC)

[bloomvest]

Great questions. My speculative answers...
Why did the company state on several occasions that the materials for Tox would be produced at the existing facility, and now the 10Q says you need to finish the new facility in order to deliver sufficient quantities of Flucide for Tox completion?

Please note that Bloomvest had previously notified you that NNVC cant make the required cides at the old facility as they have to be up to cGMP like standard, otherwise the FDA may reject the tox study.

Why did the company state that the work on Ebolacide2 would not impact the Flucide timeline for Tox (unless there were positive results from the Ebolacide2 testing) , and the 10Q says Flucide will be slowed due to Ebolacide2 development?

Please note that Bloomvest had previously notified you that NNVC is often misleading. Also while biking one day, Diwan told me he already finished ebolacide 2.

What is the current timeline for Flucide...approx when will Tox be completed, when will clinicals begin?

Please note that Bloomvest had previously notified you that NNVC cant complete tox trials until at best 2017.

You said that Flucide Tox materials were delayed by the need to divert materials to other labs, why has there been no news from any of these other labs?

Please note that Bloomvest had previously notified you that NNVC may not like the answers from the labs so NNVC goes quiet. After all NNVC investors believe no news is good news